Monitoring Rifampicin Compliance by Visual Inspection of Urine Colour

Tropical Doctor

Volumn 29, Issue 4, 1999, Pages 243-244

  Harries, A D ^a   Chilemba, P E ^a,b   Greya, D ^a,b   Nyirenda, T E ^a   Banerjee, A ^a   Salaniponi, F M L ^a  

^a National Tuberculosis Control Programme Malawi   (Malawi)

^b Mulanje District Hospital   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PATIENT COMPLIANCE; TUBERCULOSIS; URINE COLOR;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; COLOR; DRUG MONITORING; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; RIFAMPIN; URINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032830512     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947559902900418     Document Type: Article

References (5)

1. World Health Organization. Treatment of Tuberculosis: Guidelines For National Programmes, 2nd edn. Geneva: WHO, 1997.
2. Wilkinson D. High-compliance tuberculosis treatment programme in a rural community. Lancet, 1994;343:647-8.
3. Maher D, Hausler HP, Raviglione MC et al. Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis, 1997;1:276-83.
4. Elizaga J, Friedland JS. Monitoring compliance with antituberculosis treatment by detection of isoniazid in urine. Lancet, 1997;350:1225-6.
5. Peloquin CA, MacPhee AA, Berning SE. Malabsorption of antimycobacterial medications. N Engl J Med, 1993;329:1122.